| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_926a9477153fcec5755adecc4b959604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf1aa7a6105ecdd03e09425cd6392753 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59211c5bc337195e56205612135480df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65088e4f12b5b400220edfe0838e338
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504b6eede9c2e4d4ce38ecd89996a2e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf590b84a877a1642a4ead8d3eb3380e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_346f5d2957c5ebf57876237d568f32e5 |
| publicationDate |
2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017081928-A |
| titleOfInvention |
Heat resistant vaccine composition and method for preparing the same |
| abstract |
A method for producing a heat-resistant freeze-dried vaccine adjuvant-containing preparation is provided. At least one aluminum salt adjuvant, at least one buffer system containing at least one volatile salt, at least one glass former and at least one antigen are mixed together to form a liquid Producing a vaccine formulation; freezing the liquid vaccine formulation to produce a frozen vaccine formulation; lyophilizing the frozen vaccine formulation to produce a dried vaccine composition; A method wherein a dried vaccine composition is capable of eliciting an immune response in a subject. [Selection figure] None |
| priorityDate |
2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |